BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22718823)

  • 1. Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
    De Keersmaecker B; Allard SD; Lacor P; Schots R; Thielemans K; Aerts JL
    J Virol; 2012 Sep; 86(17):9351-60. PubMed ID: 22718823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.
    Van Gulck ER; Vanham G; Heyndrickx L; Coppens S; Vereecken K; Atkinson D; Florence E; Kint I; Berneman ZN; Van Tendeloo V
    J Virol; 2008 Apr; 82(7):3561-73. PubMed ID: 18234800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
    Huang XL; Fan Z; Borowski L; Rinaldo CR
    Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.
    Henry JY; Labarthe MC; Meyer B; Dasgupta P; Dalgleish AG; Galustian C
    Immunology; 2013 Jul; 139(3):377-85. PubMed ID: 23374145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.
    Van Gulck E; Cools N; Atkinson D; Bracke L; Vereecken K; Vekemans M; Van Tendeloo VF; Berneman ZN; Vanham G
    Clin Dev Immunol; 2012; 2012():184979. PubMed ID: 22844321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.
    Riou C; Burgers WA; Mlisana K; Koup RA; Roederer M; Abdool Karim SS; Williamson C; Gray CM
    J Virol; 2014 Feb; 88(3):1819-24. PubMed ID: 24227857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
    Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
    Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
    Van Gulck ER; Ponsaerts P; Heyndrickx L; Vereecken K; Moerman F; De Roo A; Colebunders R; Van den Bosch G; Van Bockstaele DR; Van Tendeloo VF; Allard S; Verrier B; Marañón C; Hoeffel G; Hosmalin A; Berneman ZN; Vanham G
    Blood; 2006 Mar; 107(5):1818-27. PubMed ID: 16263796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.
    Herath S; Benlahrech A; Papagatsias T; Athanasopoulos T; Bouzeboudjen Z; Hervouet C; Klavinskis L; Meiser A; Kelleher P; Dickson G; Patterson S
    PLoS One; 2014; 9(2):e88327. PubMed ID: 24505475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.
    Gandhi RT; Kwon DS; Macklin EA; Shopis JR; McLean AP; McBrine N; Flynn T; Peter L; Sbrolla A; Kaufmann DE; Porichis F; Walker BD; Bhardwaj N; Barouch DH; Kavanagh DG
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):246-53. PubMed ID: 26379068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.
    Kavanagh DG; Kaufmann DE; Sunderji S; Frahm N; Le Gall S; Boczkowski D; Rosenberg ES; Stone DR; Johnston MN; Wagner BS; Zaman MT; Brander C; Gilboa E; Walker BD; Bhardwaj N
    Blood; 2006 Mar; 107(5):1963-9. PubMed ID: 16249391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells.
    De Keersmaecker B; Heirman C; Allard S; Bonehill A; Corthals J; Thielemans K; Aerts JL
    Hum Gene Ther; 2010 Apr; 21(4):479-85. PubMed ID: 19903083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.
    Routy JP; Boulassel MR; Yassine-Diab B; Nicolette C; Healey D; Jain R; Landry C; Yegorov O; Tcherepanova I; Monesmith T; Finke L; Sékaly RP
    Clin Immunol; 2010 Feb; 134(2):140-7. PubMed ID: 19889582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteroclitic Peptides Increase Proliferation and Reduce Evidence of Human Immunodeficiency Virus-Specific CD8⁺ T Cell Dysfunction.
    Adegoke A; Gladney K; Gallant M; Grant M
    Viral Immunol; 2015 Oct; 28(8):455-63. PubMed ID: 26230145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.